Sopharma Trading AD (XBUL:SFT) EBIT per Share : лв0.62 (TTM As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Sopharma Trading AD EBIT per Share?

Sopharma Trading AD's EBIT per Share for the three months ended in Sep. 2023 was лв0.23. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 was лв0.62.

During the past 12 months, the average EBIT per Share Growth Rate of Sopharma Trading AD was 37.10% per year. During the past 3 years, the average EBIT per Share Growth Rate was 51.50% per year. During the past 5 years, the average EBIT per Share Growth Rate was 25.40% per year. During the past 10 years, the average EBIT per Share Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Sopharma Trading AD's EBIT per Share or its related term are showing as below:

XBUL:SFT' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -6.3 Med: 13.1 Max: 51.5
Current: 51.5

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Sopharma Trading AD was 51.50% per year. The lowest was -6.30% per year. And the median was 13.10% per year.

XBUL:SFT's 3-Year EBIT Growth Rate is ranked better than
96.3% of 81 companies
in the Medical Distribution industry
Industry Median: 6.9 vs XBUL:SFT: 51.50

Sopharma Trading AD's EBIT for the three months ended in Sep. 2023 was лв8 Mil.

Sopharma Trading AD EBIT per Share Historical Data

The historical data trend for Sopharma Trading AD's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma Trading AD EBIT per Share Chart

Sopharma Trading AD Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT per Share

Get a 7-Day Free Trial

0.41

0.54

0.43

0.51

Sopharma Trading AD Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
EBIT per Share	Get a 7-Day Free Trial															0.29	-0.37	0.43	0.32	0.23

Sopharma Trading AD EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Sopharma Trading AD's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

	EBIT per Share		(A: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	17.568	/	34.276
=	0.51

Sopharma Trading AD's EBIT per Share for the quarter that ended in Sep. 2023 is calculated as

	EBIT per Share		(Q: Sep. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	7.864	/	34.276
=	0.23

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was лв0.62

Sopharma Trading AD (XBUL:SFT) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Sopharma Trading AD EBIT per Share Related Terms

Thank you for viewing the detailed overview of Sopharma Trading AD's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma Trading AD (XBUL:SFT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma Trading AD (XBUL:SFT) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756

Website

http://www.sopharmatrading.bg

Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.

Sopharma Trading AD (XBUL:SFT) Headlines

No Headlines